Progress of Clinical Research on Trop2 in Solid Tumors by Ying ZHANG, Yueping LIU

Subjects: “…trop2…”
Get full text

RETRACTED: The role and molecular mechanism of Trop2 induced epithelial‐mesenchymal transition through mediated β‐catenin in gastric cancer by Wei Zhao, Lizhou Jia, Xingwang kuai, Qi Tang, Xiaochen Huang, Tingting Yang, Zhenning Qiu, Jin Zhu, Jianfei Huang, Wenbin Huang, Zhenqing Feng

Subjects: Get full text

Evaluation of Trop 2 expression in thyroid lesions by Vani D, Lhamo T, Adil SAK

Subjects: Get full text

Rho-ROCK liberates sequestered claudin for rapid de novo tight junction formation by Yuma Cho, Akari Taniguchi, Akiharu Kubo, Junichi Ikenouchi

Subjects: Get full text

Proteomic Changes Associated With Endogenous FBXW7 Mutations in Moderately Differentiated Endometrial Cancer Cells Include Increased TROP2 and Galectin‐3 Levels by Mary Ellen Urick, Suresh Kumar Chalapareddy, Eun‐Jeong Yu, Daphne W. Bell

Subjects: Get full text

Last Resort? Rationale for Comprehensive Molecular Analysis in Treatment-Refractory R/M HNSCC: A Case Report of Remarkable Response to Sacituzumab Govitecan Following Molecular and... by Henrike Barbara Zech, Philippe Schafhausen, Leonie Ramke, Janna-Lisa Velthaus, Simon Kreutzfeldt, Daniel Hübschmann, Kai Rothkamm, Carsten Bokemeyer, Anna Sophie Hoffmann, Stefan Fröhling, Hanno Glimm, Christian Stephan Betz, Malte Kriegs, Maximilian Christopeit

Subjects: Get full text

The tricky effects of TROP2 in lung cancer: from clinical practice back to fundamental investigations by Renwang Liu, Renwang Liu, Mingbiao Li, Penghu Gao, Penghu Gao, Xuanguang Li, Xuanguang Li, Zihe Zhang, Zihe Zhang, Jun Chen, Jun Chen

Subjects: “…Trop2…”
Get full text

From biomarker to targeted therapy: investigating trophoblast cell-surface antigen 2 expression in triple-negative breast cancer– insights from the national cancer institute by Noura A. A. Ebrahim, Mustafa A. Hussein, Mohamed Emam Sobeih, Nancy H. Amin

Subjects: “…TROP-2…”
Get full text

Noninvasive molecular imaging using anti-Trop-2 aptamer for targeted therapy of small cell lung cancer by Yamei Chen, Xuwei Liu, Yang Sun, Keying Liu, Ding Ding, Shaoli Song, Weihong Tan

Subjects: Get full text

Prognostic Value of Trop‐2 Expression in Nonmetastatic Triple‐Negative Breast Cancer and Correlation With Emerging Biomarkers by William Jacot, Marie‐Christine Chateau, Simon Thezenas, Séverine Guiu, Nelly Firmin, Virginie Lafont, Gwendal Lazennec, Charles Theillet, Florence Boissière‐Michot

Subjects: Get full text

Co-expression of tissue factor, TROP2, and NECTIN4 in primary and matched metastatic cervical cancer lesions by Marit L. Ulvang, Oda Fløtre Kvile, Hege F. Berg, Kathrine Woie, Ingfrid S. Haldorsen, Alessandro D. Santin, Bjørn I. Bertelsen, Camilla Krakstad, Mari Kyllesø Halle

Subjects: Get full text

Safety profile of sacituzumab govitecan in patients with breast cancer: A systematic review and meta-analysis by Maria Inez Dacoregio, Isabella Michelon, Caio Ernesto do Rego Castro, Francisco Cezar Aquino de Moraes, Guilherme Rossato de Almeida, Lis Victória Ravani, Maysa Vilbert, Ricardo Lima Barros Costa

Subjects: Get full text

Current status and future perspectives of antibody-drug conjugates in breast cancer therapy by LIN Jialin, WANG Wenna, XU Binghe

Subjects: “…|antibody-drug conjugate|breast cancer|targeted therapy|human epidermal growth factor receptor-2|trop-2…”
Get full text